Pelosi ’s radical plan would leave Alzheimer’s patients behind

Last month, House Speaker Nancy Pelosi unveiled aradical drug pricing plan, H.R. 3, that could jeopardize the development of innovative treatments for some of the most challenging diseases and leave U.S. patients behind. Take for example, Alzheimer ’s disease, a ruthless disease which devastates the minds of 5.7 million Americans and creates substantial burdens for families and caregivers.

Source: The Catalyst - October 16, 2019 Category: Pharmaceuticals Authors: Tom Wilbur Tags: Research and Development Economic Impact Medicare Research and Investment Source Type: news